Key points
A narrow, evidence-based reading
- Create the record before ordering, then update it at receipt and during storage.
- Keep lot-specific evidence attached to the matching physical material.
- Record missing information and deviations instead of silently resolving them.
Before procurement
Define the material and documentation your research process requires before requesting availability. A catalog name alone may not capture form, presentation, counterion, expected amount, analytical attributes, or the records your institution expects.
Document the intended nonclinical research purpose, responsible person, approval path, receiving location, and criteria for accepting or rejecting the material. The checklist should serve the actual quality process rather than become paperwork completed after the decision.
- Material specification
- Name, form, presentation, catalog identifier, and required attributes.
- Documentation need
- Lot-specific COA, method information, safety documentation, and any institutional forms.
- Responsibility
- Requester, approver, receiver, and person authorized to resolve discrepancies.
At receipt
Record what arrived before the material is separated from its shipping or transfer context. Capture the date and time, supplier, container count, label details, lot number, condition, and any available temperature or custody information.
Compare the container, request, packing information, and analytical documentation. Quarantine or otherwise control material with mismatched identifiers, damaged packaging, missing records, or an unexplained condition until the discrepancy is resolved under the laboratory's process.
- Physical check
- Container condition, closure, label legibility, and quantity received.
- Identity check
- Material, catalog code, and lot match across the container and documents.
- Receipt record
- Date, time, receiver, source, and any observed excursion or discrepancy.
Analytical-document review
Attach the complete report rather than transcribing only a purity percentage. Record the issuing laboratory, sample identifier, procedure, result, unit, acceptance criterion, date, and authorization shown on the document.
List attributes that were not tested or not reported. Identity, purity, content, water, residual solvents, microbial attributes, and stability are separate questions; the presence of one result should not be used to populate another.
During storage and use in research
Maintain a location and condition record appropriate to the laboratory's controls. Record transfers, temperature excursions, container changes, sample removals, and new identifiers assigned to working samples or aliquots.
Follow the documented storage condition for the specific material. If the supporting documentation changes, preserve the earlier version and record the review and decision rather than overwriting history.
- Location
- Controlled storage unit, position, access status, and current custodian.
- Condition
- Specified range, monitoring record, excursions, and disposition decisions.
- Movement
- Transfers, sample removals, derived identifiers, and remaining amount.
Closeout and retention
At the end of the material's research lifecycle, record the final amount, disposition, date, and responsible person. Preserve the request, receiving record, analytical documents, discrepancy notes, storage history, and disposition according to the institution's retention requirements.
This checklist is educational and does not create a quality system, certify compliance, or replace institutional procedures. It is limited to qualified laboratory, analytical, and educational research records.
Primary references
Source notes
These references provide analytical and documentation context. Citing them does not claim that Beach Bio Research catalog items are approved products or that the cited regulatory frameworks apply to a particular catalog item.
- Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical IngredientsU.S. Food and Drug Administration. Includes a detailed description of information commonly recorded on certificates of analysis.
- Q2(R2) Validation of Analytical ProceduresU.S. Food and Drug Administration. General framework for analytical-procedure validation and performance characteristics.
- Q6A Specifications: Test Procedures and Acceptance CriteriaU.S. Food and Drug Administration. Discusses identification, test procedures, specifications, and acceptance criteria.
